Please assess the completion status of the following clinical trial:

Trial Title: Study Comparing Two Tapering Strategies of Prednisone in Myasthenia Gravis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Written consent of the patient, after informing~* Generalized MG of grade III, IV or V - Classification MGFA~* Follow-up on 15 months possible and accepted by patients~Exclusion Criteria:~* Age\<18 or \>80 years~* Pregnancy~* Myasthenia of grade I or II of MGFA~* Patients already treated with prednisone or azathioprine~* Contraindication for prednisone or azathioprine~* Other associated disease requiring a treatment with prednisone or azathioprine~* Weight \>100kg~* Invasive thymoma

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Starting dose Prednisone Azathioprine (Type: ACTIVE_COMPARATOR): Classical Strategy
- Starting dose Prednisone - Azathioprine (Type: ACTIVE_COMPARATOR): Rapid strategy

Based on this trial design, predict the completion outcome and termination type (if applicable).